Want to join the conversation?
$JNJ's unit Janssen Biotech said it has entered into a clinical study collaboration agreement with $BMY to evaluate combination of two immuno-oncology compounds in patients with non-small cell lung cancer (NSCLC). Both are currently in Phase 1 clinical development: JNJ-64041757 in lung cancer and JNJ-64041809 in prostate cancer.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!